News
After years of GLP-1 ads spotlighting anonymous bellies and dancing commercial actors, telehealth firm Ro is ushering in ...
No one stays on top forever. It’s a lesson that Ozempic maker Novo Nordisk may be painfully learning about. The Danish ...
Scientists test OKV-119, a six-month implant dubbed 'Ozempup', as a new Ozempic for pets to fight obesity in cats and dogs amid rising pet health risks.
Patients' vision loss, which is rare according to a new study, is also the subject of multiple lawsuits, including two filed ...
Delhi HC protects Vicky Ramancha from coercive action in $18 million fake drugs case under EOW probe
Vicky is accused of managing an elaborate international criminal conspiracy involving the supply of counterfeit ...
Women using Ozempic are reporting rare side effects affecting their intimate areas, including dryness and discomfort. Experts advise consulting a doctor if symptoms appear.
As Novo Nordisk's sales of its blockbuster weight-loss drug Wegovy boomed, the Danish drugmaker raced to expand manufacturing ...
15h
E! Online on MSNSerena Williams Lost 31 Pounds Using GLP-1 Medication
Serena Williams recently detailed her weight loss journey, sharing that she lost 31 pounds with the assistance of a GLP-1 medication.
With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030.
7hon MSN
Layoffs loom at weight loss drug Wegovy's maker Novo Nordisk as slowing sales threaten job cuts
Novo Nordisk raced to meet demand for its weight-loss drug Wegovy and almost doubled its workforce over five years. Now, the ...
19h
The Independent on MSNHow to dine out on Ozempic: The new menus designed for a weight loss era
The new menus designed for a weight loss era - FOOD FOCUS: From luxe mini menus to teeny tiny tasting formats, restaurants ...
A WOMAN has shared her three go-to recipe which help her stay slim without resorting to Ozempic. Gina Drewalowski, who is on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results